If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,244.00    9.00 (0.73%)
Bid:
1,236.00
Ask:
1,239.00
Spread: 3.00 (0.243%)
Market Cap: £860.84m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

21 Jul 2014 07:00

RNS Number : 7799M
CVS Group plc
21 July 2014
 

 

21 July 2014

 

CVS Group plc ("CVS" or the "Group")

 

Trading Update

 

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2014. Comparative data relates to the year ended 30 June 2013 unless otherwise stated. The Group will announce its full year results on Friday 19 September 2014 and these are expected to be in line with market expectations.

 

Group revenue for the year showed total like-for-like growth of 6.9%. This figure benefitted from good weather throughout the winter months and is stated after adjusting for one extra day's trading in the year to 30 June 2013. Like-for-like sales performance was strong in all the main businesses, particularly in Animed Direct. CVS continues to see opportunities for organic growth across all of its activities and continues to invest in the estate to capitalise on this potential.

 

Strong organic growth has been achieved in the core veterinary practices especially in the second half of the year. Membership of our Healthy Pet Club loyalty schemes grew by 50,100 (44.8%), from 111,900 pets at the start of the year to 162,000 at the year end. In the previous year membership grew by 46,400. Based on the current run rate these schemes are now contributing over 11% of the total revenue from practices (2013: 9%).

 

The scale and increasing density of our practice network has enabled the Group to open four emergency out-of-hours centres during the year, bringing work previously performed by third parties into the Group. Further opportunities for similar changes will be sought during 2015.

 

Good progress has been made in developing our referrals business with organic growth continuing in the centres that we already operate. In July 2014 we purchased the freehold of Lumbry Park, Alton, Hampshire for £800,000 and we are now developing plans for fitting it out as a first-class multi-disciplinary referral centre. This centre is expected to open in the summer of 2015.

 

It is pleasing to report that significant growth has continued in Animed Direct, our online dispensary. It is currently generating some £10.4 million of annualised revenue, based on revenue for June 2014, compared with £6.7 million based on June 2013. The varying regulatory requirements in Europe have led to a slight delay in launching our planned local language European websites and the first is now expected to be launched within the next few months.

 

Acquisition activity has continued to play an important part in the Group's strategy. In addition to the seven practices acquired in the first half of the year, three practices - 3 Mile (Glasgow), Ashfield (3 sites around Halifax) and Castle (3 sites in Barnard Castle, County Durham) - and a pet crematorium (Silvermere Haven in Cobham) were acquired during the second half. These acquisitions extend the Practice Division's operations and the practices are an excellent geographic fit with the Group's existing surgeries. The acquisition of Silvermere Haven is an important step in the geographic development of our Crematoria Division and will allow almost all of our practices to be serviced internally.

 

All of the acquisitions have been successfully integrated into the Group. The aggregate turnover of acquisitions in their last financial year prior to acquisition totalled £13.3 million. The actual post acquisition turnover of businesses acquired during the year ended 30 June 2014 was £6.6m.

 

The Group now operates a total of 262 veterinary practices across the UK, an on-line dispensary, 5 diagnostic laboratories and 3 pet crematoria.

 

 

The Board is encouraged by the recent improvement in like-for-like sales performance, the continuing potential for further acquisitions and the general progress in all divisions of the Group.

 

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer (Nominated Adviser & Broker) 020 7496 3000

Aubrey Powell / Alex Wright

Nick Owen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMNDRFGDZM
Date   Source Headline
4th Dec 20209:34 amRNSGrant of Options under SAYE Scheme & PDMR Dealing
26th Nov 20203:49 pmRNSResult of AGM
26th Nov 20207:00 amRNSAGM Statement and Trading Update
23rd Nov 20207:00 amRNSHolding(s) in Company
9th Nov 20201:32 pmRNSLong Term Incentive Plan Awards & PDMR Dealing
6th Nov 20201:46 pmRNSHolding(s) in Company
4th Nov 20202:30 pmRNSPosting of Annual Report & Notice of AGM
30th Oct 20205:09 pmRNSExercise of Options
30th Sep 20207:00 amRNSExercise of Options
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement
10th Jan 20209:27 amRNSHolding(s) in Company
8th Jan 20203:57 pmRNSLong Term Incentive Plan Awards
7th Jan 20204:58 pmRNSHolding(s) in Company
6th Jan 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.